Yang Y, McLaughlin E, Naughton M, Von Ah D, Saquib N, Carroll J
Prev Oncol Epidemiol. 2025; 1(1).
PMID: 39831265
PMC: 11739934.
DOI: 10.1080/28322134.2023.2292359.
Ferrari M, Conti L, Capetti B, Marzorati C, Grasso R, Pravettoni G
Future Oncol. 2024; 20(40):3569-3578.
PMID: 39530545
PMC: 11776859.
DOI: 10.1080/14796694.2024.2421148.
Henneghan A, Van Dyk K, Haywood D, Patel M, Franco-Rocha O, Bang S
Breast Cancer Res Treat. 2024; 209(1):125-138.
PMID: 39269553
DOI: 10.1007/s10549-024-07479-4.
Janelsins M, Van Dyk K, Hartman S, Koll T, Cramer C, Lesser G
J Natl Cancer Inst. 2024; 117(2):217-228.
PMID: 39250738
PMC: 11807440.
DOI: 10.1093/jnci/djae209.
Serra-Blasco M, Souto-Sampera A, Medina J, Flix-Valle A, Ciria-Suarez L, Arizu-Onassis A
Digit Health. 2024; 10:20552076241257082.
PMID: 39070895
PMC: 11273701.
DOI: 10.1177/20552076241257082.
Exploring the Cognitive Profiles of Haemodialysis Patients using Objective and Subjective Indicators: A Cross-sectional Observational Study.
Chan F, Sim P, Lim P, Khan B, Choo J, Griva K
Int J Behav Med. 2024; .
PMID: 38918280
DOI: 10.1007/s12529-024-10301-6.
Phase III Randomized, Placebo-Controlled Clinical Trial of Donepezil for Treatment of Cognitive Impairment in Breast Cancer Survivors After Adjuvant Chemotherapy (WF-97116).
Rapp S, Dressler E, Brown W, Wade 3rd J, Le-Lindqwister N, King D
J Clin Oncol. 2024; 42(21):2546-2557.
PMID: 38709986
PMC: 11513887.
DOI: 10.1200/JCO.23.01100.
Depression Moderates the Relationship between Trait Anxiety, Worry and Attentional Control in Melanoma Survivors.
Edwards E, Chu K, John N, Edwards M, Lyvers M
Healthcare (Basel). 2023; 11(23).
PMID: 38063665
PMC: 10706424.
DOI: 10.3390/healthcare11233097.
Effects of omega-3 supplementation on psychological symptoms in men with prostate cancer: Secondary analysis of a double-blind placebo-controlled randomized trial.
Savard J, Moussa H, Pelletier J, Julien P, Lacombe L, Tiguert R
Cancer Med. 2023; 12(19):20163-20176.
PMID: 37787025
PMC: 10587967.
DOI: 10.1002/cam4.6598.
Managing Cancer and Living Meaningfully (CALM) alleviates chemotherapy related cognitive impairment (CRCI) in breast cancer survivors: A pilot study based on resting-state fMRI.
Yao S, Zhu Q, Zhang Q, Cai Y, Liu S, Pang L
Cancer Med. 2023; 12(15):16231-16242.
PMID: 37409628
PMC: 10469649.
DOI: 10.1002/cam4.6285.
Young Adults' Lived Experiences with Cancer-Related Cognitive Impairment: An Exploratory Qualitative Study.
Sharma S, Brunet J
Curr Oncol. 2023; 30(6):5593-5614.
PMID: 37366905
PMC: 10297401.
DOI: 10.3390/curroncol30060422.
Validating the PROMIS cognitive function short form in cancer survivors.
Henneghan A, Van Dyk K, Zhou X, Moore R, Root J, Ahles T
Breast Cancer Res Treat. 2023; 201(1):139-145.
PMID: 37330430
PMC: 10729147.
DOI: 10.1007/s10549-023-06968-2.
Epigenetic aging in older breast cancer survivors and noncancer controls: preliminary findings from the Thinking and Living with Cancer Study.
Rentscher K, Bethea T, Zhai W, Small B, Zhou X, Ahles T
Cancer. 2023; 129(17):2741-2753.
PMID: 37259669
PMC: 10659047.
DOI: 10.1002/cncr.34818.
The high burden of symptoms associated with cognitive impairment in lung cancer patients: A latent class analysis.
Luo J, Liu R, Luo Y, Fang Q, Liu S, Yang Z
Asia Pac J Oncol Nurs. 2023; 10(4):100200.
PMID: 36890861
PMC: 9988398.
DOI: 10.1016/j.apjon.2023.100200.
Cognitive and neuroimaging outcomes in individuals with benign and low-grade brain tumours receiving radiotherapy: a protocol for a prospective cohort study.
Hardy S, Finkelstein A, Tivarus M, Culakova E, Mohile N, Weber M
BMJ Open. 2023; 13(2):e066458.
PMID: 36792323
PMC: 9933762.
DOI: 10.1136/bmjopen-2022-066458.
Remote, Computerised Cognitive Assessment for Breast Cancer- and Treatment-Related Cognitive Dysfunction: Psychometric Characteristics of the Cogsuite Neurocognitive Battery.
Root J, Gaynor A, Ahsan A, Jung D, Schofield E, Ryan E
Arch Clin Neuropsychol. 2023; 38(5):699-713.
PMID: 36655820
PMC: 10369363.
DOI: 10.1093/arclin/acac111.
The Fast Cognitive Evaluation (FaCE): a screening tool to detect cognitive impairment in patients with cancer.
Baghdadli A, Arcuri G, Green C, Gauthier L, Gagnon P, Gagnon B
BMC Cancer. 2023; 23(1):35.
PMID: 36624397
PMC: 9830916.
DOI: 10.1186/s12885-022-10470-1.
Impact of chronic graft-versus-host disease on quality of life and cognitive function of long-term transplant survivors after allogeneic hematopoietic stem cell transplantation with total body irradiation.
Gruber I, Koelbl O, Herr W, Holler E, Edinger M, Wolff D
Radiat Oncol. 2022; 17(1):195.
PMID: 36447269
PMC: 9706937.
DOI: 10.1186/s13014-022-02161-9.
What is the impact of targeted therapies given within phase I trials on the cognitive function of patients with advanced cancer: a mixed-methods exploratory study conducted in an early clinical trials unit.
Stapleton S, Darlington A, de Bono J, Wiseman T
BMJ Open. 2022; 12(11):e050590.
PMID: 36442900
PMC: 9710342.
DOI: 10.1136/bmjopen-2021-050590.
Impact of psychosocial, behavioral and lifestyle factors on subjective cognitive complaints and perceived quality of life in a large cohort of Italian breast cancer patients.
West T, Cavallero C, Ceccherini R, Foladore S, Generali D, Versace F
Front Psychol. 2022; 13:1015573.
PMID: 36438336
PMC: 9683534.
DOI: 10.3389/fpsyg.2022.1015573.